Great progress in the understanding of the molecular genetics of inflammatory bowel
disease (IBD) has been made over the last 10 years. Strong epidemiological evidence …

The Asia–Pacific region has been marked as an area with a low incidence of inflammatory
bowel disease (IBD), although confusion always existed as to whether this low incidence …

The application of genetic information to diagnosis and risk prediction in inflammatory bowel
disease will require comprehensive knowledge of the relevant susceptibility alleles …

Recent studies have greatly improved our insight into the genetic background of
inflammatory bowel disease (IBD). New high‐throughput technologies and large‐scale …

Inflammatory bowel disease (IBD) is a chronic, relapsing intestinal inflammatory disorder
with unidentified causes. Both environmental factors and genetic aspects are believed to be …

The genetic revolution has been with us for over a decade now. We have yet to see this
impacting the care of patients except in a few rare examples. However, progress has been …

Abstract Background and Aims The inflammatory bowel diseases (IBDs) Crohn's disease
(CD) and ulcerative colitis are complex disorders with an important genetic determinant. One …

There is a general consensus that interplay of genetic and environmental factors leads to an
overactive mucosal immune response, which mediates the tissue damage in inflammatory …

Objective Crohn9s disease (CD) is an intractable inflammatory bowel disease (IBD) of
unknown cause. Recent meta-analysis of the genome-wide association studies (GWAS) and …

Crohn's disease and ulcerative colitis constitute two major subgroups of inflammatory bowel
diseases (IBD), a group of complex polygenic diseases characterized by chronic and …